For example, circulating CAFs can be detected in the blood of both breast cancer and prostate cancer with high levels of CAFs, and circulating CAFs exist in 88% of metastatic breast cancer patients and 23% of non metastatic patients (based on the expression of FAP and actin alpha 2 ACTA2) [49]. Here, FAP is linked to breast carcinoma.